MSCI's closely balanced 50% market-implied probability for beating Q3 2026 estimates reflects uncertainty following its July miss of $4.94 EPS versus consensus near $4.99, which triggered a sharp stock decline. Analysts project $5.00-$5.03 EPS and roughly $880-900 million revenue for the quarter ending September, implying 11-12% year-over-year growth driven by index segment strength and asset-based fees. Recent downward revisions to price targets by firms including JPMorgan and Morgan Stanley, alongside modest estimate adjustments over the past month, have offset positive earnings surprise history in prior periods. The October 20 release before the open, with its associated conference call, stands as the immediate catalyst that could shift odds based on actual results relative to guidance and any updates on recurring revenue trends.